Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Ochenduszko, Sebastian; Garcia, Javier; Juan-Fita, Maria Jose; Gonzalez-Barrallo, Ines; Colomina, Julio Herrero; Beveridge, Robert Diaz; Martinez, Silverio Ros; Lafuente, Blanca Sanchez; Tomas, Alberto Jacobo Cunquero; Berrocal, Alfonso; Cerezuela-Fuentes, Pablo; Fra, Pablo Luna; Peeters, Alicia Gervas; Gonzalez, Jose Luis Sanchez; Garcia, Andres Meana; Garcia, Mariasun Algarra; Garcia, Eugenio Palomares; Altozano, Javier Perez; Guerola, Monica Tallon; Maestu, Inmaculada. Real-world study on characteristics of advanced melanoma patients with sustained complete response (CR) after elective 1st line anti-programmed death-1 (anti-PD1) monotherapy discontinuation.. JOURNAL OF CLINICAL ONCOLOGY. 2022; 40(16).
AÑO: 2022; IF: 50.717
Garcia del Muro, Xavier; Riva, Francois; Andres Cuellar, M.; Maroto-Rey, Pablo; Castellano, Daniel E.; Giannatempo, Patrizia; Climent Duran, Miguel Angel A.; Necchi, Andrea; Perez-Valderrama, Begona; De Liano Lista, Alfonso Gomez; Garcias-Espana, Carmen; Puente, Javier; Ros, Silverio; Santander, Carmen; Masini, Cristina; Martinez de Falcon, Marta; Garcia, Almudena; Sampayo-Cordero, Miguel; Malfettone, Andrea; Paez, David. A phase 2 study of the efficacy and safety of INCMGA00012 in advanced penile squamous cell carcinoma (PSqCC): ORPHEUS.. JOURNAL OF CLINICAL ONCOLOGY. 2022; 40(6). 10.1200/JCO.2022.40.6_suppl.TPS8
AÑO: 2022; IF: 50.717
Encarnación JA, Cerezuela P, Español I, García MR, Manso C, De la Fuente I, Garrigós N, Viney A, Minguillon J, Surrallés J. Fanconi-like anemia related to a FANCM mutation. Eur J Med Genet. 2022 Jan;65(1):104399. doi: 10.1016/j.ejmg.2021.104399. Epub 2021 Nov 15. PubMed PMID: 34793962.
AÑO: 2022; IF: 2.465
Castillo-Guardiola V, Rosado-Jiménez L, Sarabia-Meseguer M, Marín-Vera M, Macías-Cerrolaza JA, García-Hernández R, Zafra-Poves M, Sánchez-Henarejos P, Moreno-Locubiche MÁ, Cuevas-Tortosa E, Arnaldos-Carrillo M, Ayala-de-la-Peña F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance. Eur J Med Genet. 2022 Mar 1:104468. doi: 10.1016/j.ejmg.2022.104468. [Epub ahead of print] PubMed PMID: 35245693.
AÑO: 2022; IF: 2.465
Martín M, Zielinski C, Ruiz-Borrego M, Carrasco E, Ciruelos EM, Muñoz M, Bermejo B, Margelí M, Csöszi T, Antón A, Turner N, Casas MI, Morales S, Alba E, Calvo L, de la Haba-Rodríguez J, Ramos M, Murillo L, Santaballa A, Alonso-Romero JL, Sánchez-Rovira P, Corsaro M, Huang X, Thallinger C, Kahan Z, Gil-Gil M. Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study. Eur J Cancer. 2022 Apr 13;168:12-24. doi: 10.1016/j.ejca.2022.03.006. [Epub ahead of print] PubMed PMID: 35429901.
AÑO: 2022; IF: 10.002
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII